M&A Deal Summary

Johnson & Johnson Acquires Momenta Pharmaceuticals

On August 19, 2020, Johnson & Johnson acquired life science company Momenta Pharmaceuticals for 6.5B USD

Acquisition Highlights
  • This is Johnson & Johnson’s 15th transaction in the Life Science sector.
  • This is Johnson & Johnson’s 7th largest (disclosed) transaction.
  • This is Johnson & Johnson’s 33rd transaction in the United States.
  • This is Johnson & Johnson’s 4th transaction in Massachusetts.

M&A Deal Summary
Date 2020-08-19
Target Momenta Pharmaceuticals
Sector Life Science
Buyer(s) Johnson & Johnson
Deal Type Add-on Acquisition
Deal Value 6.5B USD

Target

Momenta Pharmaceuticals

Cambridge, Massachusetts, United States
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis of complex drugs. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications. Momenta Pharmaceuticals was founded in 2001 and is based in Cambridge, Massachusetts.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Johnson & Johnson

New Brunswick, New Jersey, United States
Category Company
Founded 1886
Sector Consumer Products
Employees132,000
Revenue 85.2B USD (2023)
DESCRIPTION
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.

Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.

DEAL STATS #
Overall 40 of 45
Sector (Life Science) 15 of 18
Type (Add-on Acquisition) 32 of 36
State (Massachusetts) 4 of 5
Country (United States) 33 of 37
Year (2020) 1 of 1
Size (of disclosed) 7 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-20 TARIS Biomedical

Lexington, Massachusetts, United States

TARIS Biomedical LLC is a privately-owned biotechnology company specializing in the development of a novel drug delivery technology for the treatment of bladder diseases including cancer.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-01 Abiomed

Danvers, Massachusetts, United States

Abiomed is a cardiovascular device company. Abiomed develops, manufactures, and markets medical products designed to establish recovery's as the standard of care for acute patients. Abiomed was formed in 1981 and is based in Danvers, Massachusetts.

Buy $16.6B
Mergr

Product

Company

Legal